Summary
Updated Aug 31, 2026
Michael F. Roman files SEC Form 4 reports at ABBOTT LABORATORIES (ABT). 7 SEC Form 4 filings on record going back to 2024, most recently on 1 July 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Michael F. Roman has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael F. Roman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Luxco S.A R.L. Derby - $304.51M of WAY open-market activity in the last 12 months
- CANADA PENSION PLAN INVESTMENT BOARD - $232.86M of WAY open-market activity in the last 12 months
- BAIN CAPITAL INVESTORS LLC - $168.41M of WAY open-market activity in the last 12 months
- Paul G. Moskowitz - $168.41M of WAY open-market activity in the last 12 months
- Robert B. Ford - $48.22M of ABT open-market activity in the last 12 months
- Matthew J. Hawkins - $4.64M of WAY open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Michael F. Roman?
Michael F. Roman is a corporate insider of ABBOTT LABORATORIES (ABT). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Michael F. Roman submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Where can I see all of Michael F. Roman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Michael F. Roman and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
